Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02079636
Title A Study of LY2835219 in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
UCLA Department of Medicine-Hematology/Oncology Los Angeles California 90095 United States Details
University of California, Davis - Health Systems Sacramento California 95817 United States Details
Indiana Cancer Pavilion Indianapolis Indiana 46202 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
University of New Mexico Cancer Center Albuquerque New Mexico 87102 United States Details
Carolinas Medical Center Charlotte North Carolina 28204 United States Details
The West Clinic Germantown Tennessee 38138 United States Details
Hospital Universitario Ramon y Cajal Madrid 28034 Spain Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Majadahonda 28222 Spain Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field